Cite
MLA Citation
Michelle L. D'Antoni et al.. “Brief Report: Bictegravir/Emtricitabine/Tenofovir Alafenamide Efficacy in Participants With Preexisting Primary Integrase Inhibitor Resistance Through 48 Weeks of Phase 3 Clinical Trials.” Journal of acquired immune deficiency syndromes, vol. 89, 2022, pp. 433–440. http://access.bl.uk/ark:/81055/vdc_100151260225.0x000010